Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …

Skeletal muscle‐related symptoms are common in both acute coronavirus disease (Covid)‐
19 and post‐acute sequelae of Covid‐19 (PASC). In this narrative review, we discuss …

Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

Understanding the impact of COVID-19 on muscle strength may help to elucidate the organ
systems that contribute to acute and chronic COVID-19 sequelae. We questioned whether …

Background Few studies have evaluated muscle strength in COVID-19 ICU survivors. We
aimed to report the incidence of limb and respiratory muscle weakness in COVID-19 ICU …

Objectives Severe forms of the novel coronavirus-19 (COVID-19) are associated with
systemic inflammation and hypercatabolism. The aims of this study were to compare the time …

Purpose Symptoms often persistent for more than 4 weeks after COVID-19—now commonly
referred to as 'Long COVID'. Independent of initial disease severity or pathological …

Purpose To evaluate if reduced muscle mass, assessed with Computed Tomography (CT),
is a predictor of intensive care unit (ICU) hospitalization in COVID-19 patients. Methods In …

Introduction It has become increasingly evident that COVID-19 contributes to multiorgan
pathophysiology. The systemic inflammatory response increases both pro-inflammatory …

Background There is limited information about the impact of coronavirus disease (COVID‐
19) on the muscular dysfunction, despite the generalized weakness and fatigue that patients …